Clinical Trial

A Study in People With Overweight or Obesity to Compare How 2 Different Formulations of Survodutide Are Taken up by the Body

Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
The primary objective of this trial is to assess bioequivalence of two formulations of survodutide (formulation A and formulation B6) after multiple-dose treatment in male and female trial participants living with overweight or obesity.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2026-02-06; most recent amendment 2026-06-15.
Status change: Not Yet Recruiting → Recruiting 2026-03-16
Trial Details
NCT Number NCT07407348
Lead Sponsor Boehringer Ingelheim
Conditions Healthy, Obesity, Overweight
Enrollment 80 participants
Start Date 2026-03-11
Primary Completion 2027-01-26 (estimated)
Study Completion 2027-03-02 (estimated)
Updated on ClinicalTrials.gov 2026-07-30